Cytosorbents (CTSO) Intangibles (2018 - 2026)
Cytosorbents (CTSO) posted Intangibles of $3.0 million for Q1 2026, down 8.49% on a QoQ basis from $3.2 million in Q4 2025, and down 20.32% year-over-year from $3.7 million in Q1 2025.
Cytosorbents (CTSO) Intangibles (2018 - 2026) Analysis & Trends
Cytosorbents' Intangibles history runs 9 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Intangibles fell 20.32% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 20.32% YoY) and the FY2025 annual result came in at $3.2 million, down 13.3% from the prior year.
- Intangibles was $3.0 million for Q1 2026 at Cytosorbents, down from $3.2 million in the prior quarter.
- Across five years, Intangibles topped out at $4.4 million in Q4 2022 and bottomed at $3.0 million in Q1 2026.
- A 5-year average of $3.7 million and a median of $3.7 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles declined 4.75% — and 2026, when it dropped 20.32%.
- Cytosorbents' Intangibles stood at $4.4 million in 2022, then declined by 11.02% to $3.9 million in 2023, then declined by 4.75% to $3.7 million in 2024, then dropped by 13.3% to $3.2 million in 2025, then retreated by 8.49% to $3.0 million in 2026.
- Business Quant data shows CTSO's Intangibles at $3.0 million in Q1 2026, $3.2 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.14 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 882.00 Mn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.95 Mn |
| Dec 31, 2025 | 3.23 Mn |
| Sep 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 4.39 Mn |
| Dec 31, 2021 | 4.70 Mn |
| Dec 31, 2020 | 4.22 Mn |
| Dec 31, 2019 | 3.36 Mn |
| Dec 31, 2018 | 2.63 Mn |